目的分析糖尿病患者低血糖恐惧感的影响因素,并结合影响因素结果讨论聚焦解决干预模式的方法。方法选取2023年1—12月福州市第二总医院收治的120例出现低血糖的糖尿病患者,应用中文版低血糖恐惧感调查-忧虑量表(Chinese Version Hypogly...
详细信息
目的分析糖尿病患者低血糖恐惧感的影响因素,并结合影响因素结果讨论聚焦解决干预模式的方法。方法选取2023年1—12月福州市第二总医院收治的120例出现低血糖的糖尿病患者,应用中文版低血糖恐惧感调查-忧虑量表(Chinese Version Hypoglycemia Fear SurveyⅡ-Worry Scale,CHFSⅡ-WS)评估,分析糖尿病患者低血糖恐惧感影响因素。结果经单因素分析发现,不同糖尿病患者年龄、糖尿病病程、半年内低血糖发生次数、低血糖严重程度、自我管理能力的糖尿病患者的CHFSⅡ-WS评分比较,差异均有统计学意义(P均<0.05)。多元线性回归分析结果显示:年龄>60岁、糖尿病病程≥10年、半年内低血糖发生>6次、重度低血糖是低血糖恐惧感的危险因素,糖尿病自我管理行为量表评估结果好为低血糖恐惧感的保护因素(P均<0.05)。结论年龄、糖尿病病程、半年内低血糖发生次数、低血糖严重程度、自我管理能力是糖尿病患者低血糖恐惧的影响因素,针对存在危险因素的糖尿病患者采取聚焦解决干预模式,以降低患者低血糖恐惧感。
目的:探讨不同左室射血分数(LVEF)水平与心力衰竭人群肾功能障碍的关联。方法:以2006年至2018年期间参与开滦集团健康体检并于2020年12月31日前首次确诊心力衰竭的个体为研究对象,按照LVEF Objective: To investigate the association b...
详细信息
目的:探讨不同左室射血分数(LVEF)水平与心力衰竭人群肾功能障碍的关联。方法:以2006年至2018年期间参与开滦集团健康体检并于2020年12月31日前首次确诊心力衰竭的个体为研究对象,按照LVEF Objective: To investigate the association between different levels of left ventricular ejection fraction (LVEF) and renal dysfunction in patients with heart failure. Methods: Individuals who participated in the Kailuan Group health examinations between 2006 and 2018 and were first diagnosed with heart failure by December 31, 2020, were included as the study population. Participants were categorized into three groups based on LVEF levels: LVEF < 40%, 40% ≤ LVEF < 50%, and LVEF ≥ 50%. LVEF was used as the independent variable, and the presence of renal dysfunction was used as the dependent variable. A binary logistic regression model was constructed to calculate odds ratios (ORs) and their 95% confidence intervals (CIs). Subgroup analyses were performed according to age, sex, and obesity. Additionally, sensitivity analyses were conducted by excluding individuals with a history of hypertension, diabetes, myocardial infarction, or pre-existing chronic kidney disease (CKD) to verify the robustness of the results. Results: A total of 3272 participants were included in this study, of whom 2837 (86.7%) were male, with a mean age of 68.01 ± 10.99 years. Logistic regression analysis showed that, compared with the reference group (LVEF ≥ 50%), the odds ratios (ORs) for renal dysfunction were 1.73 (95% CI: 1.31~2.29) in the 40% ≤ LVEF < 50% group and 2.42 (95% CI: 1.72~3.41) in the LVEF < 40% group. Subgroup analysis revealed that, except for the female subgroup, which showed no statistically significant difference, the results were consistent with the overall analysis across all other subgroups. Conclusion: The risk of renal dysfunction increases progressively with the decline in LVEF among patients with heart failure.
暂无评论